News

Patient Power's MPN Patient Survey

MPN News | 10/21/19

As researchers around the world seek to accelerate progress in medicine it's important for patients to share their stories to promote greater understanding. Patient Power has partnered with Dr. Naveen Pemmaraju to find out more about how patients use online resources to guide their car

Read More

New Trial Recruiting Primary, Post-PV, and Post-ET Myelofibrosis Patients

MPN News | 10/15/19

CTI Biopharma is recruiting patients for the PACIFCA trial, a randomized phase 3 study evaluating PACRITINIB in patients with MF.

Read More

The Fall 2019 Newsletter is Here

MPN News | 10/3/19

Your copy of the Fall 2019 Newsletter from the MPN Research Foundation is now available.

Read More

Pegylated Interferon Leads to High Response Rates in ET & PV After Hydroxyurea

MPN News | 10/1/19

ASH Clinical News reports on the results of an open-label, phase II clinical trial published in Blood.

Read More

Today is Rare Cancer Day!

MPN News | 10/1/19

The big day is here - Rare Cancer Day! Launched by the National Organization for Rare Disorders (NORD) and the NORD Rare Cancer Coalition, the goal of #RareCancerDay is to raise critical awareness of rare cancers and the need for greater research funding and patient support.

Read More

Geron Receives Fast Track Designation to Imetelstat for Myelofibrosis

MPN News | 9/30/19

More possible good news for upcoming therapies for myeloproliferative neoplasms. Geron was granted fast-track designation by FDA for imetelstat, which they have pursued in people with Intermediate-2 Myelofibrosis

Read More

MPN Research Foundation Announces 2019-2020 Grantees for MPN Challenge Grant program

MPN News | 9/23/19

The MPN Research Foundation is thrilled to announce the award of seven new projects as part of the MPN Challenge Grant program, a partnership between MPNRF and The Leukemia & Lymphoma Society. The following projects applied and reviewed in a competitive, peer-reviewed process that took place this past July in Chicago.

Read More

Pegasys users may now access resources to help with reimbursement issues through Genentech

MPN News | 9/10/19

For more information about the Genentech Patient Foundation and to learn if a patient receiving a Genentech product (such as Pegasys) is eligible to receive support, please visit www.gene.com/patients/patient-foundation or call the Patient Resource Center at 877-GENENTECH.

Read More

Patient Advocates Take Aim at Progression in Myeloproliferative Neoplasms

MPN News | 9/10/19

Through a one-year pilot grant, the MPN Research Foundation (MPNRF) will provide funding to Dr. Ann Mullally and Dana-Farber Cancer Institute's Center for Prevention of Progression (CPOP) to study the genomic basis for MPN disease progression

Read More

Imago BioSciences Granted Fast Track Designation for IMG-7289 in Myelofibrosis

MPN News | 9/6/19

Imago BioSciences announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development of IMG-7289 (bomedemstat) for the treatment of myelofibrosis.

Read More

Blood Cancer Awareness Month 2019

MPN News | 9/3/19

September provides the MPN community a unique opportunity to draw attention to polycythemia vera, essential thrombocythemia, and myelofibrosis by celebrating nationally recognized Blood Cancer Awareness Month.

Read More

How mutations express themselves in blood-cell production

MPN News | 8/15/19

A method for detecting mutations and measuring gene-expression levels in the same cell has enabled an investigation into the effects of mutations in a specific gene on the emergence of a form of blood cancer..

Read More

Clinical Cancer Research Publishes Article on Myelofibrosis

MPN News | 8/15/19

Targeting the Aurora Kinase A Inhibition has potential benefit for patients with myelofibrosis.

Read More

Verstovsek Outlines Features of and Therapies for Myeloproliferative Neoplasms

MPN News | 8/02/19

In an article published by Targeted Oncology, Dr. Srdan Verstovsek, MD, Ph., discussed with a group of physicians the considerations he makes with the diagnosis and management of patients with myeloproliferative neoplasms (MPNs).

Read More

Mark Your Calendars - October 1 is Rare Cancer Day!

MPN News | 8/29/19

The National Organization for Rare Disorders (NORD) has announced a day devoted to raising awareness about rare cancers. Spearheaded by the NORD Rare Cancer Coalition, which is comprised of 24 rare cancer-specific Member Organizations.

Read More

Check our News - Archive for older news.

Get updates on MPN patients and research breakthroughs.

What are the latest developments in MPN Research?